When Amgros is to estimate resource consumption, we ask relevant departments and hospital pharmacies to answer specific questions in relation to the use of the equal pharmaceuticalsRead more
When the patent on a pharmaceutical expires, and generic or biosimilar alternatives enter the market, Amgros’ task is to ensure the widest possible competition.READ MORE
If a new drug is to be considered as a standard treatment at Danish public hospitals, the Danish Medicines Council has to assess it first.READ MORE
Head of Business Intelligence and Health Economy
I’m responsible for operation and development of business intelligence and health economics. I make sure that our department can proudly claim to be the partner who gets things done.